investor login

contact

team

dedicated funds

news

 portfolio

Developer of a molecular diagnostics technology designed to dramatically reduce time to results in microbiology. The company’s Field Activated Sample Treatment (FAST) technology uses a novel electrical lysing and sample treatment technique that enables the rapid detection of infectious agents in a direct blood sample, enabling clinicians to detect and identify micro-organisms in infected whole blood samples without the need for culturing or time consuming sample processing.

 

 

Active, HVP V, Med Tech

back to portfolio

contact

© hatteras venture partners | all rights reserved | terms + privacy | site credit

 team

 portfolio

news

home

Hatteras Venture Partners is a venture capital firm that builds transformational companies in areas of health innovation.

dedicated funds

contact

 team

dedicated funds

news

home

 portfolio